Literature DB >> 7442085

Immune status in Crohn's disease. 4. In vitro antibody dependent cell mediated cytotoxicity in peripheral blood.

I O Auer, E Ziemer.   

Abstract

In Crohn's disease (CD) a potential etiopathogenetic role of the antibody dependent cell mediated cytotoxicity (ADCC) has been discussed. By means of a 51Cr release assay with an established human lymphoblastoid cell line as target, the in vitro ADCC activity was studied in the peripheral blood of 34 patients with CD. 11 patients with inflammatory bowel disease other than CD or ulcerative colitis (group D) and 45 sex and age matched healthy people served as controls. In unseparated mononuclear cell suspensions, we found a significantly lower ADCC activity in CD patients and in group D than in normals. Depletion of both phagocytic and plastic adherent cells, i.e. macrophages, resulted in complete normalisation of the ADCC activity in all patients of group D and also two-thirds of the CD patients. However, the remaining one third CD patients still exhibited ADCC activity below 1 standard deviation of normal. Most of these latter CD patients had highly active disease. Thus, this study showes that the general ADCC per se is normal in CD, except for a decrease in patients with high activity of disease. However, the normal general ADCC activity per se is significantly suppressed by phagocytic, plastic adherent cells. In this regard similar results were found in group D.

Entities:  

Mesh:

Year:  1980        PMID: 7442085     DOI: 10.1007/bf01478286

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  44 in total

1.  Effector cell activity in antibody mediated cell dependent immune lysis. II. Evidence for different populations of effector cells for different targets.

Authors:  T Kovithavongs; G Rice; K L Thong; J B Dossetor
Journal:  Cell Immunol       Date:  1975-07       Impact factor: 4.868

2.  Loss of specific natural cell-mediated cytotoxicity with absorption of natural antibodies from serum.

Authors:  D Akira; M Takasugi
Journal:  Int J Cancer       Date:  1977-06-15       Impact factor: 7.396

3.  Studies of antibody-dependent cytotoxicity in a plaque assay: evidence of human monocyte-like effector cells.

Authors:  L Thorsteinsson; S S Frøland; J B Natvig
Journal:  Scand J Immunol       Date:  1977       Impact factor: 3.487

4.  Lymphocyte antibody lymphocytolytic interaction (LALI) with special emphasis on HL-A.

Authors:  G Trinchieri; M De Marchi; W Mayr; M Savi; R Ceppellini
Journal:  Transplant Proc       Date:  1973-12       Impact factor: 1.066

5.  Monocyte kinetic studies in normal and disease states.

Authors:  G Meuret; G Hoffmann
Journal:  Br J Haematol       Date:  1973-03       Impact factor: 6.998

6.  K-lymphocytes (killer-cells) in Crohn's disease and acute virus B-hepatitis.

Authors:  R Eckhardt; P Kloos; M P Dierich; K H Meyer zum Büschenfelde
Journal:  Gut       Date:  1977-12       Impact factor: 23.059

7.  Antibody-dependent cell-mediated cytotoxicity: heterogeneity of effector cells in human peripheral blood.

Authors:  H R MacDonald; G D Bonnard; B Sordat; S A Zawodnik
Journal:  Scand J Immunol       Date:  1975-09       Impact factor: 3.487

8.  Heterogeneity of lymphocyte subpopulations in severe combined immunodeficiency. Evidence against a stem cell defect.

Authors:  R H Buckley; R B Gilbertsen; R I Schiff; E Ferreira; S O Sanal; T A Waldmann
Journal:  J Clin Invest       Date:  1976-07       Impact factor: 14.808

9.  Human antibody-dependent cell-mediated cytotoxicity against target cells infected with respiratory syncytial virus.

Authors:  R Scott; M O de Landazuri; P S Gardner; J J Owen
Journal:  Clin Exp Immunol       Date:  1977-04       Impact factor: 4.330

10.  Antibody-dependent cell-mediated cytotoxicity in humans. I. Characterization of the effector cell.

Authors:  G Trinchieri; P Bauman; M De Marchi; Z Tökés
Journal:  J Immunol       Date:  1975-07       Impact factor: 5.422

View more
  7 in total

1.  Effects of nutritional therapy on chemiluminescence in Crohn's disease.

Authors:  N Okabe; K Maeda; M Okada; M Ueki; T Sakurai; T Matsui; T Yao
Journal:  Dig Dis Sci       Date:  1991-11       Impact factor: 3.199

2.  Circulating soluble factor-inhibiting natural killer (NK) activity of fresh peripheral blood mononuclear cells (PBMC) from inflammatory bowel disease (IBD) patients.

Authors:  R Giacomelli; A Passacantando; G Frieri; I Parzanese; S D'Alò; P Vernia; M T Pimpo; C Petrucci; R Caprilli; M G Cifone; G Tonietti
Journal:  Clin Exp Immunol       Date:  1999-01       Impact factor: 4.330

3.  Immunological studies on Crohn's disease. V. Enumeration of circulating lymphocytes subsets using monoclonal antibodies.

Authors:  N Okabe; K Fujita; M Yamasaki; T Yao; S Tsuru
Journal:  Gastroenterol Jpn       Date:  1985-10

4.  Depressed T cell reactivity to recall antigens in Crohn's disease before and after surgical resection.

Authors:  G D'Haens; M Hiele; P Rutgeerts; K Geboes; J L Ceuppens
Journal:  Gut       Date:  1994-12       Impact factor: 23.059

5.  Immune status in Crohn's disease. V. Decreased in vitro natural killer cell activity in peripheral blood.

Authors:  I O Auer; E Ziemer; H Sommer
Journal:  Clin Exp Immunol       Date:  1980-10       Impact factor: 4.330

6.  Depressed spontaneous cell-mediated cytotoxicity in Crohn's disease.

Authors:  W L Beeken; B R Macpherson; R M Gundel; S St Andre-Ukena; S G Wood; D L Sylwester
Journal:  Clin Exp Immunol       Date:  1983-02       Impact factor: 4.330

7.  Ulcerative colitis specific cytotoxic IgG-autoantibodies against colonic epithelial cancer cells.

Authors:  I O Auer; L Grosch; C Hardörfer; A Röder
Journal:  Gut       Date:  1988-12       Impact factor: 23.059

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.